TSX:CWEB • CA16106R1091
The current stock price of CWEB.CA is 1.07 CAD. In the past month the price increased by 48.61%. In the past year, price increased by 664.29%.
ChartMill assigns a technical rating of 9 / 10 to CWEB.CA. When comparing the yearly performance of all stocks, CWEB.CA is one of the better performing stocks in the market, outperforming 99.21% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to CWEB.CA. CWEB.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months CWEB.CA reported a non-GAAP Earnings per Share(EPS) of -0.19. The EPS increased by 39.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.58% | ||
| ROE | -234.52% | ||
| Debt/Equity | 5.28 |
For the next year, analysts expect an EPS growth of 35% and a revenue growth 5.55% for CWEB.CA
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.41 | 3.067B | ||
| CRON | CRONOS GROUP INC | 37.59 | 1.395B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.273B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 7.5 | 947.204M | ||
| WEED | CANOPY GROWTH CORP | N/A | 630.302M | ||
| GUD | KNIGHT THERAPEUTICS INC | 132.78 | 628.91M | ||
| NGEN | NERVGEN PHARMA CORP | N/A | 458.223M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 28.22 | 384.256M | ||
| TSND | TERRASCEND CORP | N/A | 341.596M | ||
| HITI | HIGH TIDE INC | 27 | 316.584M |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, sales, and marketing of hemp-derived cannabidiol and other botanical-based wellness products. The company is headquartered in Louisville, Colorado and currently employs 112 full-time employees. The company went IPO on 2018-08-29. Charlotte's Web branded full-spectrum CBD products start with proprietary hemp genetics that are 100% North American farm grown and manufactured into hemp extracts containing naturally occurring phytocannabinoids, including cannabidiol (CBD), cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids and other beneficial hemp compounds. Charlotte’s Web product categories include functional mushroom gummies, and hemp extract oil tinctures (liquid products), gummies, capsules, topical creams and lotions, and pet products. The company also produces NSF Certified for Sport broad-spectrum tincture and gummy products. Charlotte’s Web products are distributed to retail outlets and health care practitioners, and online through its Website at www.charlottesweb.com and other third-party e-commerce sites.
CHARLOTTES WEB HOLDINGS INC
700 Tech Court
Louisville COLORADO 80302 US
CEO: Adrienne Deanie Elsner
Employees: 112
Phone: 17206177303
Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, sales, and marketing of hemp-derived cannabidiol and other botanical-based wellness products. The company is headquartered in Louisville, Colorado and currently employs 112 full-time employees. The company went IPO on 2018-08-29. Charlotte's Web branded full-spectrum CBD products start with proprietary hemp genetics that are 100% North American farm grown and manufactured into hemp extracts containing naturally occurring phytocannabinoids, including cannabidiol (CBD), cannabichromene (CBC), cannabigerol (CBG), cannabinol (CBN), terpenes, flavonoids and other beneficial hemp compounds. Charlotte’s Web product categories include functional mushroom gummies, and hemp extract oil tinctures (liquid products), gummies, capsules, topical creams and lotions, and pet products. The company also produces NSF Certified for Sport broad-spectrum tincture and gummy products. Charlotte’s Web products are distributed to retail outlets and health care practitioners, and online through its Website at www.charlottesweb.com and other third-party e-commerce sites.
The current stock price of CWEB.CA is 1.07 CAD. The price increased by 8.08% in the last trading session.
CWEB.CA does not pay a dividend.
CWEB.CA has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
CHARLOTTES WEB HOLDINGS INC (CWEB.CA) operates in the Health Care sector and the Pharmaceuticals industry.
CHARLOTTES WEB HOLDINGS INC (CWEB.CA) will report earnings on 2026-03-17, after the market close.